Sunday, October 30, 2016 12:12:40 AM
I don't think PW would sell out at anytime in the near future, he has been in this game for far too long to just give in on the cusp of greatness for Clinuvel. I think the recent share price hike from $5.20 to $6.40 or thereabouts proved that rises such as these can be sustained, I'm deeply hoping there won't be a severe pullback as profit taking occurs. My take: another surge will happen on Monday regardless of whether the report is released in the morning or afternoon, be it from new interest generated from the phenomenal hike or lack of available shares. The report will further this surge but their could be a pullback later in the week. However I think the stock will remain permanently above $10.
Incredible to think that we will be at $10 whereas I was certain this figure wasn't going to appear until the middle of next year. This stock is starting to take on a price boom characteristic that can occur with other pharmaceutical stocks, for example a nascent pharma with a Phase 2 cancer drug where stakeholders bet on future prospects well before time. However, the difference with Clinuvel is that it is a bona fide company with revenue and possible first profit coming soon. Given this solid foundation that Clinuvel has, stakeholders could accumulate and new investors could drive the price well ahead to a level that is not commensurate to Clinuvel's fundamentals.
I do hope this occurs quickly though, but at the same time it makes for a nervous experience. Will have to rely on Kenny Rogers' advice from 'The Gambler"...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM